Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015
- PMID: 28488996
- PMCID: PMC5434885
- DOI: 10.2807/1560-7917.ES.2017.22.17.30521
Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015
Abstract
In Germany, routine childhood varicella vaccination was implemented in 2004 with two doses recommended since 2009. We used an immunisation information system based on countrywide health insurance claims data to analyse vaccine effectiveness (VE) and factors influencing VE. We applied proportional hazard models to estimate VE under various conditions and compared the risk of acquiring varicella among unvaccinated children in regions with high vs low vaccination coverage (VC). Among 1.4 million children we identified 29,404 varicella cases over a maximum follow-up of 8 years post-vaccination. One-dose VE was 81.9% (95% confidence interval (CI): 81.4-82.5), two-dose VE 94.4% (95% CI: 94.2-94.6). With dose one given 1-27 days after measles-containing vaccine (MCV), one-dose VE was 32.2% (95% CI: 10.4-48.6), two-dose VE 92.8% (95% CI: 84.8-96.6). VE was not associated with age at vaccination (11-14 vs ≥ 15 months), time since vaccination, or vaccine type. Unvaccinated children had a twofold higher risk of acquiring varicella in low VC regions. Our system generated valuable data, showing that two-dose varicella vaccination provides good protection for at least 8 years. Unvaccinated children benefit from herd effects. When the first varicella vaccine dose is given shortly after MCV, a second dose is essential.
Keywords: administrative data; herd immunity; immunization information system; vaccination coverage; vaccine effectiveness; varicella virus infection (chickenpox).
This article is copyright of The Authors, 2017.
Conflict of interest statement
Figures


Similar articles
-
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085. Pediatrics. 2006. PMID: 16740809
-
Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China.Vaccine. 2018 Sep 5;36(37):5665-5670. doi: 10.1016/j.vaccine.2018.05.025. Epub 2018 Aug 10. Vaccine. 2018. PMID: 30104113
-
Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.Pediatr Infect Dis J. 2014 Nov;33(11):1164-8. doi: 10.1097/INF.0000000000000444. Pediatr Infect Dis J. 2014. PMID: 24911894 Free PMC article.
-
[Systematic reviews and evidence quality assessment on effectiveness of 1 dose varicella attenuated live vaccine for healthy children aged 1-12 years in China].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jul 10;41(7):1138-1144. doi: 10.3760/cma.j.cn112338-20191025-00762. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 32741184 Chinese.
-
Varicella vaccination in Japan: necessity of implementing a routine vaccination program.J Infect Chemother. 2013 Apr;19(2):188-95. doi: 10.1007/s10156-013-0577-x. Epub 2013 Mar 13. J Infect Chemother. 2013. PMID: 23483311 Review.
Cited by
-
Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: A retrospective observational study.Front Public Health. 2022 Nov 8;10:1039537. doi: 10.3389/fpubh.2022.1039537. eCollection 2022. Front Public Health. 2022. PMID: 36424959 Free PMC article.
-
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.Vaccine. 2023 May 16;41(21):3328-3336. doi: 10.1016/j.vaccine.2023.04.007. Epub 2023 Apr 7. Vaccine. 2023. PMID: 37087395 Free PMC article.
-
Immunity to Varicella Zoster Virus in Healthcare Workers: A Systematic Review and Meta-Analysis (2024).Vaccines (Basel). 2024 Sep 6;12(9):1021. doi: 10.3390/vaccines12091021. Vaccines (Basel). 2024. PMID: 39340051 Free PMC article. Review.
-
Seroprevalence for vaccine-preventable diseases among Italian healthcare workers.Hum Vaccin Immunother. 2021 May 4;17(5):1342-1346. doi: 10.1080/21645515.2020.1818523. Epub 2020 Oct 5. Hum Vaccin Immunother. 2021. PMID: 33017204 Free PMC article.
-
Effectiveness of two-dose vs. one-dose varicella vaccine in children in Shanghai, China: a prospective cohort study.Front Public Health. 2024 Jun 4;12:1320407. doi: 10.3389/fpubh.2024.1320407. eCollection 2024. Front Public Health. 2024. PMID: 38894987 Free PMC article.
References
-
- Centers for Disease Control Prevention. About Immunization Information Systems [internet]. 2012 May 15 [cited 2017 Apr 25]. Available from: http://www.cdc.gov/vaccines/programs/iis/about.html
-
- Siedler A, Rieck T, Reuss A, Walter D, Poggensee G, Poethko-Muller C, et al. Estimating vaccination coverage in the absence of immunisation registers--the German experience. Euro Surveill. 2012;17(17):20152. - PubMed
-
- Robert Koch Institute (RKI). KV-Impfsurveillance: Ergänzungen zu den Impfdaten aus den Schuleingangsuntersuchungen. [ASHIP vaccination monitoring: Complements to vaccination data from school entrance examinations]. Epid Bull 2016;16:134. German. Available from: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2016/Ausgaben/16_16...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical